Zinofil Tablet
By Zinofil
Rx
10 Tablet in a Strip

Composition
Diethylcarbamazine(150mg) + Cetirizine(5mg)

Manufacturer - Med Manor Organics Pvt Ltd
16-11-477/45, Dilsukh Nagar, Hyderabad-500036, Telangana, India.

Expires on or after
June, 2026

liver
Jilosyn 150mg/5mg Tablet is considered safe for patients with liver disease. Current information indicates that there may not be a requirement to adjust the dosage of Jilosyn 150mg/5mg Tablet for individuals with liver issues. It is advisable to consult your healthcare provider for personalized guidance and monitoring.

kidney
Jilosyn 150mg/5mg Tablet requires caution in kidney disease. Dosage adjustment might be necessary. Avoid in severe kidney disease. Potential for increased drowsiness in end-stage kidney disease patients. Consult your doctor for personalized guidance.

alcohol
When taking Jilosyn 150mg/5mg Tablet, be cautious as it can lead to increased drowsiness when consumed with alcohol.

driving
When taking Jilosyn 150mg/5mg Tablet, be cautious while driving as it may reduce alertness, cause vision changes, or lead to drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
"It is better to consult your doctor before using Jilosyn 150mg/5mg Tablet."

breastfeeding
It is better to consult your doctor before using Jilosyn 150mg/5mg Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹55
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024